Medicare Enrolled
Dr. Alex Glazer, M.D.
Dermatopathology Physician · Buffalo Grove, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Glazer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Glazer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Glazer
Dr. Alex Glazer is a dermatopathology physician in Buffalo Grove, IL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Glazer performed 5,405 Medicare services across 3,416 unique beneficiaries.
Between the years covered by Open Payments, Dr. Glazer received a total of $86,780 from 35 pharmaceutical and/or device companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatopathology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Glazer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 27% volume in IL
$86,780 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,405
Medicare services
Top 27% in IL for dermatopathology physician
3,416
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~491 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Destruction of precancerous skin growths, 2-14 This procedure involves the removal or destruction of two to fourteen precancerous skin lesions. It is performed to eliminate abnormal skin cells that have the potential to develop into cancer. |
1,093 | $5 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
864 | $65 | $160 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
637 | $1 | $20 |
| Skin biopsy, tangential A procedure to remove a sample of the first identified skin growth for laboratory examination. |
604 | $69 | $325 |
| Destruction of precancerous skin growth, 1 Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer. |
447 | $37 | $145 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
369 | $41 | $100 |
| Additional skin growth biopsy Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session. |
295 | $42 | $175 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
282 | $76 | $235 |
| Destruction of skin growths (warts/lesions), 1-14 This procedure involves the removal or destruction of one to fourteen skin growths. It is a minor surgical intervention performed on the skin surface. |
265 | $85 | $240 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
164 | $10 | $55 |
| Injection into skin growths, 1-7 A procedure involving the injection of medication into one to seven skin growths. |
80 | $34 | $115 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
71 | $46 | $165 |
| Punch biopsy of first skin growth A small, circular piece of skin is removed from a skin growth using a circular blade. The sample is then sent to a laboratory for examination. |
41 | $100 | $405 |
| Intermediate wound repair, 2.6-7.5 cm A medical procedure to close a wound on the scalp, underarms, trunk, arms, or legs that measures between 2.6 and 7.5 centimeters. This type of repair involves cleaning the wound and stitching it closed to promote healing. |
34 | $239 | $660 |
| Ear tissue biopsy A procedure to remove a small sample of tissue from the ear for laboratory examination. |
26 | $46 | $425 |
| Simple drainage of skin abscess A minor procedure to drain a localized collection of pus from the skin. The abscess is opened to allow the fluid to escape and promote healing. |
20 | $83 | $255 |
| Skin cancer removal, face or mouth area, 0.6-1.0 cm Surgical removal of a cancerous skin growth from the face, ears, eyelids, nose, lips, or mouth. The procedure involves excising a lesion measuring between 0.6 and 1.0 centimeters. |
19 | $107 | $525 |
| Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | 15 | $262 | $645 |
| Destruction of cancer skin growth, 0.6-1.0 cm This procedure involves the removal or destruction of a cancerous skin growth located on the trunk, arms, or legs that measures between 0.6 and 1.0 centimeters. |
15 | $101 | $315 |
| Destruction of cancer skin growth, 1.1-2.0 cm Removal of a cancerous skin growth on the trunk, arms, or legs that measures between 1.1 and 2.0 centimeters. |
15 | $127 | $340 |
| Intermediate wound repair, 2.5 cm or less This procedure involves stitching a wound on the scalp, underarms, trunk, arms, or legs that is 2.5 centimeters or smaller. It includes cleaning the wound and closing it with sutures to promote healing. |
13 | $187 | $520 |
| Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm | 13 | $152 | $410 |
| Removal of noncancer skin growth, 0.6-1.0 cm This procedure involves the removal of a benign skin growth located on the body, arms, or legs. The growth removed measures between 0.6 and 1.0 centimeters in diameter. |
12 | $73 | $325 |
| Surgical removal of skin cancer, 1.1-2.0 cm Surgical excision of a cancerous skin growth measuring between 1.1 and 2.0 centimeters on the body, arms, or legs. |
11 | $104 | $545 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$86,780
Total received (2018-2024)
Avg $12,397/year across 7 years
Top 17% in IL for dermatopathology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
650
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$60,273 (69.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,840 (19.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,667 (11.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$48,264
2023
$27,373
2022
$5,027
2021
$4,937
2020
$1,041
2019
$13
2018
$125
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Arcutis Biotherapeutics, Inc.
$38,161
UCB, Inc.
$8,312
ABBVIE INC.
$489
GENZYME CORPORATION
$317
Journey Medical Corporation
$151
Dermavant Sciences, Inc.
$106
LEO Pharma Inc.
$98
MAYNE PHARMA COMMERCIAL LLC
$94
Regeneron Healthcare Solutions, Inc.
$86
Novartis Pharmaceuticals Corporation
$66
Incyte Corporation
$57
Verrica Pharmaceuticals Inc.
$53
Genentech USA, Inc.
$50
SUN PHARMACEUTICAL INDUSTRIES INC.
$40
E.R. Squibb & Sons, L.L.C.
$39
Smith+Nephew, Inc.
$36
Amgen Inc.
$33
Galderma Laboratories, L.P.
$30
PFIZER INC.
$29
Ortho Dermatologics, a division of Bausch Health US, LLC
$17
Top 3 companies account for 97.3% of 2024 payments
All-time payments by company (2018-2024) ›
Arcutis Biotherapeutics, Inc.
$54,921
UCB, Inc.
$10,185
Incyte Corporation
$4,772
E.R. Squibb & Sons, L.L.C.
$2,643
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,495
ABBVIE INC.
$1,981
EPI Health, LLC
$1,610
AbbVie Inc.
$879
Sun Pharmaceutical Industries Inc.
$834
Lilly USA, LLC
$797
GENZYME CORPORATION
$791
Regeneron Healthcare Solutions, Inc.
$738
Janssen Biotech, Inc.
$554
Novartis Pharmaceuticals Corporation
$409
SUN PHARMACEUTICAL INDUSTRIES INC.
$362
LEO Pharma Inc.
$311
Journey Medical Corporation
$308
Dermavant Sciences, Inc.
$287
Amgen Inc.
$266
Galderma Laboratories, L.P.
$241
Genentech USA, Inc.
$227
PFIZER INC.
$168
MAYNE PHARMA COMMERCIAL LLC
$167
MAYNE PHARMA INC.
$149
Ortho Dermatologics, a division of Bausch Health US, LLC
$138
VYNE Pharmaceuticals Inc.
$129
Allergan, Inc.
$124
SANOFI-AVENTIS U.S. LLC
$80
Verrica Pharmaceuticals Inc.
$53
Celgene Corporation
$53
Smith+Nephew, Inc.
$36
Sandoz Inc.
$24
Almirall LLC
$21
Mayne Pharma Inc.
$13
Mission Pharmacal Company
$11
Top 3 companies account for 80.5% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · AMZEEQ · ARAZLO · Absorica LD · Avar · BOTOX · Bimzelx · CIBINQO · CLODERM · COSENTYX · CYLTEZO · Cimzia · DORYX · DUOBRII · DUPIXENT · ENSTILAR · EUCRISA · Enbrel · Erivedge · GRAFIX PL · HUMIRA · ILUMYA · Ilumya · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · STELARA · Seysara · Sitavig · Sotyktu · TALTZ · TREMFYA · VTAMA · WYNZORA · Winlevi · Xolair · YCANTH · ZILXI · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
Dermatopathology physicians within 10 mi
6
Per 100K population
0.8
County median income
$108,917
Nearest hospital
NORTHWESTERN LAKE FOREST HOSPITAL
7.0 mi
7.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Glazer is a clinical cardiology specialist, with above-average Medicare volume (top 27% in IL), with consulting-driven industry engagement in the top 17% of IL peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Glazer experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Glazer performed 1,093 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Glazer receive payments from pharmaceutical companies?
Yes. Dr. Glazer received a total of $86,780 from 35 companies across 650 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Glazer's costs compare to other dermatopathology physicians in Buffalo Grove?
Dr. Glazer's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Glazer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Dermatopathology Physicians in Buffalo Grove
Browse dermatopathology physicians in Buffalo Grove ranked by procedure volume and transparency data.
Highest volume
Top Dermatopathology Physicians in IL
Dermatopathology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Dermatopathology Physicians in IL
Which IL dermatopathology physicians receive the most from drug and device companies.
By company
Arcutis Biotherapeutics, Inc. Payments to Doctors
See all physicians who received payments from Arcutis Biotherapeutics, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology